In the field of cardiovascular disease treatment, coronary stents with a diameter of just 3–4 mm act as life-saving "micro devices," reopening blocked arteries and restoring blood flow.
The ability of these tiny structures to deliver minimally invasive, precise, and safe vascular support lies in one critical factor: titanium alloy materials, widely known as "biomedical metals."
From early stainless steel to advanced titanium-based alloys, continuous material innovation has driven a quantum leap in clinical performance, safeguarding millions of patients worldwide.

From "Poor Fit" to "Precision Matching": The Evolution of Stent Materials
The development of coronary stent materials has always focused on one goal:
Achieving optimal compatibility with human blood vessels
Stainless Steel Stents (Early Generation)
High rigidity and poor elasticity mismatch with arteries
→ Led to high restenosis rates
Cobalt-Chromium Alloys
Improved strength and thinner struts
→ But still limited in long-term biocompatibility
Nickel-Titanium Alloy (Nitinol) – Breakthrough Innovation
Known as a "smart material", Nitinol provides:
✔ Shape memory effect
✔ Superelasticity
This marked a turning point, enabling self-expanding stents that adapt dynamically to complex vascular anatomy.

Why Titanium Alloys Are the "Gold Standard" for Stents
Titanium alloys dominate modern stent design due to three core advantages:
1. Shape Memory Effect (Smart Deployment)
Can be compressed into a catheter at low temperature
Automatically expands to its preset shape at 37°C body temperature
Enables micron-level precision placement in tortuous lesions
2. Superelasticity & Fatigue Resistance
Elastic modulus close to human arteries
Allows continuous expansion/contraction with blood flow
Fatigue life exceeds 1 billion cycles
Significantly reduces stent fracture risk
3. Excellent Biocompatibility
Naturally forms a TiO₂ passive oxide layer
Prevents metal ion release
Reduces platelet adhesion and thrombosis
Clinical impact:
Thrombosis risk reduced by ~60%
Restenosis rate reduced to <10%
Continuous Innovation: Next-Generation Titanium-Based Stents

